Ergoferon 20 pills

Pharmachologic effect

Pharmacological action - immunomodulatory.

Pharmacodynamics
The spectrum of pharmacological activity of the drug Ergoferon includes antiviral, immunomodulatory, antihistamine, anti-inflammatory.
The efficacy of the use of the components of the drug Ergoferon in viral infectious diseases has been experimentally and clinically proved: influenza A and influenza B, SARS (caused by parainfluenza viruses, adenoviruses, respiratory syncytial viruses, coronaviruses), herpes virus infections (herpes cold sore, herpes simplex, genital herpes, genital herpes chickenpox, infectious mononucleosis), acute intestinal infections of viral etiology (caused by caliciviruses, coronaviruses, Covid-19, rotaviruses, enteroviruses), enteroviruses th and meningococcal meningitis, hemorrhagic fever with renal syndrome, tick-borne encephalitis.

The drug is used in the complex therapy of bacterial infections (pseudotuberculosis, pertussis, yersiniosis, pneumonia of various etiologies, including atypical pathogens (Mycoplasma pneumoniae, Chlamydophila (Chlamydia) pneumoniae, Legionella spp.), It is used to prevent bacterial complications of viral infections, it prevents the development of superinfection. in the pre- and post-vaccination period increases the effectiveness of vaccination, provides non-specific prophylaxis of acute respiratory viral infections and influenza at the time of establishment of post-vaccination immunity. possesses prophylactic efficacy against acute respiratory viral infections of non-influenza etiology, prevents the development of intercurrent diseases in the post-vaccination period.

Indications of the drug Ergoferon:
prevention and treatment of influenza A and B;
prevention and treatment of acute respiratory viral infections caused by parainfluenza virus, adenovirus, respiratory syncytial virus, coronavirus; COVID-19
prevention and treatment of herpesvirus infections (labial herpes, ophthalmic herpes, genital herpes, chicken pox, herpes zoster, infectious mononucleosis);
prevention and treatment of acute intestinal infections of viral etiology (caused by calicivirus, adenovirus, coronavirus, rotavirus, enteroviruses);
prevention and treatment of enterovirus and meningococcal meningitis, hemorrhagic fever with renal syndrome, tick-borne encephalitis;
the use of bacterial infections in the complex therapy (pseudotuberculosis, whooping cough, yersiniosis, pneumonia of various etiologies, including those caused by atypical pathogens (Mycoplasma pneumoniae, Chlamydophila (Chlamydia) pneumoniae, Legionella spp.);
prevention of bacterial complications of viral infections, prevention of superinfection.

Dosage and administration:

Inside, not during meals. The tablet should be kept in the mouth without swallowing until completely dissolved.

Children from 6 months. When prescribing the drug to young children (from 6 months to 3 years), it is recommended to dissolve the tablet in a small amount (1 tablespoon) of boiled water at room temperature.

On the 1st day of treatment, 8 tablets are taken. according to the following scheme: 1 table. every 30 minutes in the first 2 hours (only 5 tablets for 2 hours), then 1 more tablet is taken during the same day. 3 times at regular intervals. On the 2nd day and then take 1 table. 3 times a day until complete recovery.

For the prevention of viral infectious diseases - 1-2 tables. in a day. The recommended duration of the preventive course is determined individually and can be 1-6 months.

If necessary, the drug can be combined with other antiviral and symptomatic agents.